Perez, J. R.; Hernández, R.; Lage, Y.; Rupérez, A. B.; Ruiz, E.; Hernández, T.; Doger, B.; Garcia-Foncillas, J.; Moreno</p, V. Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient Treated With a Novel Combination Treatment With Anti PDL1 Antibody (Durvalumab) and VEGFR2 Antibody (Ramucirumab). acmcr 2020, 4, 8-14.